ELEVEN THERAPEUTICS CORP
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $3.0M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | ENCINITAS, California |
| Industry | unknown |
| Stage | unknown |
| Website | eleventx.com |
xRNA next-gen mRNA therapeutics platform using AI plus combinatorial chemistry to optimize RNA components. Built around partnered programs including with the Gates Foundation, Cambridge, and Twist Bioscience. Differentiates on every-component RNA optimization rather than capping work.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $3.0M | undisclosed |
Detected tech stack
Nginx, WordPress 7.0, Yoast SEO 27.6, Google Analytics, Google Tag Manager, GSAP, Swiper, DoubleClick Floodlight, cdnjs, Contact Form 7 6.1.6, WOW 1.0.0, Cloudflare
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | eleventx.com, read 2026-05-02 |
| Description | self-reported | eleventx.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.